Screening for Obstructive Sleep Apnea Among Members of an Internet Weight Loss Community

Obstructive Sleep Apnea Clinical Trial

Official title:

Effect of a Web-Based Presentation on Communication With Healthcare Providers

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00808574
• Other study ID #: HSC-MS-08-0346
• Status: Completed
• Phase: Phase 0
• First received: December 12, 2008
• Last updated: December 12, 2008
• Start date: July 2008
• Est. completion date: October 2008

Study information

• Verified date: December 2008
• Source: The University of Texas Health Science Center, Houston
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

The current study was a pilot, double blind, randomized controlled trial to (1) evaluate the feasibility of an online obstructive sleep apnea (OSA) screening intervention, (2) estimate effect size for planning of future studies, and (3) test the hypothesis that the intervention, compared to a control condition, would lead more individuals to discuss OSA with their healthcare provider.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 168
• Est. completion date: October 2008
• Est. primary completion date: October 2008
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Member of SparkPeople.com community and logged on within previous month

• Live in the US

Exclusion Criteria:

• Prior diagnosis of OSA

• Prior discussions with healthcare provider about OSA

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Screening

Related Conditions & MeSH terms

• Obstructive Sleep Apnea
• Sleep Apnea Syndromes
• Sleep Apnea, Obstructive

Intervention

Behavioral:
• Obstructive sleep apnea screening intervention
Brief, theory-based, online assessment of OSA risk followed by risk-tailed OSA presentation.

Locations

Country	Name	City	State
United States	University of Texas Medical School, Houston	Houston	Texas

Sponsors (1)

Lead Sponsor	Collaborator
The University of Texas Health Science Center, Houston

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Online questionnaire asking whether subject has discussed OSA with healthcare provider since enrolling in study		12 weeks	No
Secondary	Online questionnaire asking whether subject has plans to discuss OSA with healthcare provider, if not done already		12 weeks	No
Secondary	Online questionnaire asking whether subject has undergone testing and treatment for OSA since enrolling in study		12 weeks	No